What's Next for Cremascoli Ortho?
Executive Summary
One of the few mid-sized European orthopedic companies to build a continental presence, Cremascoli has been extremely successful. But now it contemplates its future in an industry driven by consolidation.
You may also be interested in...
Stanmore: Creating a Specialty Orthopedics Company
Long a pioneer in prosthetics, one of orthopedics' forgotten spaces, Stanmore Implants Worldwide, has a new investor group who hope to transform this once academic supplier into a thriving orthopedics player by focusing on specialty niches that the Ortho giants have largely ignored.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”